Skip to main content

Table 6 Relevancy feedback performance in terms of WSS@95% on DERP systematic review collections

From: Improving reference prioritisation with PICO recognition

 

[120]

[121]

LR

PICO

Δ

ACE Inhibitors

74.3

*82.7

74.7

74.4

-0.3

ADHD

67.9

*82.1

67.5

68.9

1.4

Antihistamines

*24.5

17.7

-1.7

-1.9

-0.1

Atypical Antipsychotics

18.0

*33.6

18.0

20.5

2.5

Beta Blockers

65.0

*68.5

54.7

55.7

1.1

Calcium Channel Blockers

17.3

12.8

*47.6

47.1

-0.5

Estrogens

22.6

28.5

36.6

*39.1

2.4

NSAIDS

*77.4

64.1

60.9

63.1

2.2

Opioids

9.0

17.4

19.5

*34.1

14.6

Oral Hypoglycemic

13.5

*15.9

6.9

9.2

2.3

Proton Pump Inhibitors

19.7

21.0

*21.2

18.3

-2.9

Skeletal Muscle Relaxants

*58.6

29.9

25.9

32.4

6.5

Statins

27.8

*43.7

42.9

43.3

0.3

Triptans

39.6

*54.1

34.3

52.4

18.1

Urinary Incontinence

20.8

41.6

44.8

*46.4

1.6

Average

37.1

40.9

36.9

40.2

3.3

  1. Δindicates the change between adding the PICO features to the baseline logistic regression classifier (LR)
  2. *indicate best performance per review